Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             31 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Alone, lonely, and missed Kahn, James

9 6 p. 565-566
artikel
2 A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19 McGonagle, Dennis

9 6 p. 665-672
artikel
3 Challenges and opportunities to end tuberculosis in the COVID-19 era Wingfield, Tom

9 6 p. 556-558
artikel
4 Correction to Lancet Respir Med 2021; published online April 9. https://doi. org/10.1016/S2213-2600(21)00160-0
9 6 p. e55
artikel
5 Correction to Lancet Respir Med 2021; published online April 19. https://doi.org/10.1016/S2213-2600(21)00096-5
9 6 p. e55
artikel
6 Correction to Lancet Respir Med 2021; published online April 9. https://doi. org/10.1016/S2213-2600(21)00171-5
9 6 p. e55
artikel
7 Correction to Lancet Respir Med 2021; published online Feb 26. https://doi.org/10.1016/S2213-2600(20)30448-3
9 6 p. e55
artikel
8 COVID-19 pathophysiology: looking beyond acute disease The Lancet Respiratory Medicine,

9 6 p. 545
artikel
9 COVID-19 survivor experiencing long-term symptoms Kirby, Tony

9 6 p. 570-572
artikel
10 Desperation in the time of COVID-19 Adhikari, Biplov

9 6 p. 567-569
artikel
11 Development of new antibacterial agents: a sense of urgency needed Burki, Talha Khan

9 6 p. e54
artikel
12 Early humoral response among lung transplant recipients vaccinated with BNT162b2 vaccine Shostak, Yael

9 6 p. e52-e53
artikel
13 Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study Yap, Timothy A

9 6 p. 613-621
artikel
14 Evidence-based European guidelines for the diagnosis of asthma in children aged 5–16 years Gaillard, Erol A

9 6 p. 558-560
artikel
15 From female warriors in the rainforest to infectious disease specialists: COVID-19 in the Amazon Safe, Izabella

9 6 p. 566-567
artikel
16 Has the time come to end use of the blue inhaler? Bush, Andrew

9 6 p. e51
artikel
17 High COVID-19 death rates in prisons in England and Wales, and the need for early vaccination Braithwaite, Isobel

9 6 p. 569-570
artikel
18 Immunotherapy in COVID-19: why, who, and when? Sinha, Pratik

9 6 p. 549-551
artikel
19 Integrating new therapies for systemic sclerosis-associated lung fibrosis in clinical practice Khanna, Dinesh

9 6 p. 560-562
artikel
20 Interleukin-6: obstacles to targeting a complex cytokine in critical illness McElvaney, Oliver J

9 6 p. 643-654
artikel
21 Interleukin-6 receptor blockade in patients with COVID-19: placing clinical trials into context Angriman, Federico

9 6 p. 655-664
artikel
22 Lung microbiota predict chronic rejection in healthy lung transplant recipients: a prospective cohort study Combs, Michael P

9 6 p. 601-612
artikel
23 New and old treatments for malignant mesothelioma: not just immunotherapy Nowak, Anna K

9 6 p. 547-549
artikel
24 Non-invasive respiratory support strategies in COVID-19 Gorman, Ellen

9 6 p. 553-556
artikel
25 REPLACE and the role of riociguat in pulmonary arterial hypertension therapy Frantz, Robert P

9 6 p. 546-547
artikel
26 Rucaparib in patients with BAP1-deficient or BRCA1-deficient mesothelioma (MiST1): an open-label, single-arm, phase 2a clinical trial Fennell, Dean A

9 6 p. 593-600
artikel
27 Saliva as a gold-standard sample for SARS-CoV-2 detection Tan, Steph H

9 6 p. 562-564
artikel
28 Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial Hoeper, Marius M

9 6 p. 573-584
artikel
29 Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial de Gooijer, Cornedine J

9 6 p. 585-592
artikel
30 The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity Osuchowski, Marcin F

9 6 p. 622-642
artikel
31 Vascular mechanisms and manifestations of COVID-19 Levi, Marcel

9 6 p. 551-553
artikel
                             31 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland